The Asia-Pacific region presents immense opportunities for healthcare investors, as massive populations, developing private markets, and government-led initiatives are driving innovation across the region’s healthcare systems and medical technology. China’s biopharma sector has firmly positioned itself among global leaders in therapeutic innovation leading to several multibillion-dollar licensing agreements between domestic drug developers and international pharma giants. Meanwhile, India’s rapidly developing VC ecosystem is powering an emerging healthtech hub, and PE investors have deployed billions into Japanese markets.
Read the full article: PitchBook: APAC Healthcare Market Snapshot //
Source: https://pitchbook.com/news/reports/2025-apac-healthcare-market-snapshot